Cargando…
The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study
Accumulating evidence has revealed that both high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) are associated with increased risk of metabolic syndrome (MetS) and cardiovascular disease. However, it is unclear whether the coexistence of these conditions accelerates the risk of metab...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198954/ https://www.ncbi.nlm.nih.gov/pubmed/30352089 http://dx.doi.org/10.1371/journal.pone.0206157 |
_version_ | 1783365046488793088 |
---|---|
author | Kim, Jinkwan Pyo, Sangshin Yoon, Dae Wui Lee, Seungkwan Lim, Ja-Yun Heo, June seok Lee, Seungku Shin, Chol |
author_facet | Kim, Jinkwan Pyo, Sangshin Yoon, Dae Wui Lee, Seungkwan Lim, Ja-Yun Heo, June seok Lee, Seungku Shin, Chol |
author_sort | Kim, Jinkwan |
collection | PubMed |
description | Accumulating evidence has revealed that both high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) are associated with increased risk of metabolic syndrome (MetS) and cardiovascular disease. However, it is unclear whether the coexistence of these conditions accelerates the risk of metabolic syndrome (MetS). We hypothesized that the combination of high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) levels could exacerbate the development of MetS in a large prospective cohort study. We selected data from 3,170 individuals (1,614 men and 1,556 women) who participated in the Korean Genome and Epidemiology Study. Participants with high hsCRP and HCY levels were categorized into quartiles. MetS was defined based on the criteria of the modified National Cholesterol Education Program, Adult Treatment Panel III. The prevalence of MetS was higher in participants with concurrent high hsCRP and HCY compared to those with low hsCRP and HCY levels. The incidence of MetS at the 6-year follow-up was the highest in participants with concomitant high hsCRP and HCY levels, regardless of obesity. Even after adjusting for potential confounding factors including body mass index in a multivariate logistic regression model, subjects with elevated hsCRP and HCY levels had a 2.50-fold increased risk of developing MetS at the six-year follow-up compared to those who did not have high hsCRP and HCY level. MetS is more prevalent in the concurrent presence of elevated hsCRP and HCY levels. The combination of the two conditions may contribute to an increased risk of MetS, but these factors may not be synergistic. |
format | Online Article Text |
id | pubmed-6198954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61989542018-11-19 The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study Kim, Jinkwan Pyo, Sangshin Yoon, Dae Wui Lee, Seungkwan Lim, Ja-Yun Heo, June seok Lee, Seungku Shin, Chol PLoS One Research Article Accumulating evidence has revealed that both high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) are associated with increased risk of metabolic syndrome (MetS) and cardiovascular disease. However, it is unclear whether the coexistence of these conditions accelerates the risk of metabolic syndrome (MetS). We hypothesized that the combination of high sensitivity C-reactive protein (hsCRP) and homocysteine (HCY) levels could exacerbate the development of MetS in a large prospective cohort study. We selected data from 3,170 individuals (1,614 men and 1,556 women) who participated in the Korean Genome and Epidemiology Study. Participants with high hsCRP and HCY levels were categorized into quartiles. MetS was defined based on the criteria of the modified National Cholesterol Education Program, Adult Treatment Panel III. The prevalence of MetS was higher in participants with concurrent high hsCRP and HCY compared to those with low hsCRP and HCY levels. The incidence of MetS at the 6-year follow-up was the highest in participants with concomitant high hsCRP and HCY levels, regardless of obesity. Even after adjusting for potential confounding factors including body mass index in a multivariate logistic regression model, subjects with elevated hsCRP and HCY levels had a 2.50-fold increased risk of developing MetS at the six-year follow-up compared to those who did not have high hsCRP and HCY level. MetS is more prevalent in the concurrent presence of elevated hsCRP and HCY levels. The combination of the two conditions may contribute to an increased risk of MetS, but these factors may not be synergistic. Public Library of Science 2018-10-23 /pmc/articles/PMC6198954/ /pubmed/30352089 http://dx.doi.org/10.1371/journal.pone.0206157 Text en © 2018 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kim, Jinkwan Pyo, Sangshin Yoon, Dae Wui Lee, Seungkwan Lim, Ja-Yun Heo, June seok Lee, Seungku Shin, Chol The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title | The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title_full | The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title_fullStr | The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title_full_unstemmed | The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title_short | The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study |
title_sort | co-existence of elevated high sensitivity c-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: a 6-year follow-up study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198954/ https://www.ncbi.nlm.nih.gov/pubmed/30352089 http://dx.doi.org/10.1371/journal.pone.0206157 |
work_keys_str_mv | AT kimjinkwan thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT pyosangshin thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT yoondaewui thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT leeseungkwan thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT limjayun thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT heojuneseok thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT leeseungku thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT shinchol thecoexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT kimjinkwan coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT pyosangshin coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT yoondaewui coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT leeseungkwan coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT limjayun coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT heojuneseok coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT leeseungku coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy AT shinchol coexistenceofelevatedhighsensitivitycreactiveproteinandhomocysteinelevelsisassociatedwithincreasedriskofmetabolicsyndromea6yearfollowupstudy |